| Heidi L Feichtinger, | |
|
100 University Dr, Amherst, MA 01002-2357 | |
| (413) 582-0100 | |
| (413) 582-0159 |
| Full Name | Heidi L Feichtinger |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 100 University Dr, Amherst, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174042196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Heidi L Feichtinger, 100 University Dr, Amherst, MA 01002-2357 Ph: (413) 582-0100 | Heidi L Feichtinger, 100 University Dr, Amherst, MA 01002-2357 Ph: (413) 582-0100 |
News Archive
In an early indication of lay opinions on research with induced pluripotent stem cells, which are stem cells made from skin or other tissues, a new study by bioethicists at Johns Hopkins University indicates that despite some ethical concerns, patients give the research "broad endorsement".
These parity-induced mammary epithelial cells (PI-MEC) have the ability to self-renew over many generations and to differentiate into numerous cellular subtypes.
In Japan, 40 percent of lung cancer cases are detected on early stages and treated with a high probability of remission; in the US 20 percent of cases have that possibility, while in Mexico, in the National Cancer Institute (INCan), only 1.2 percent of patients are diagnosed at an early stage.
Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.
Arteriocyte, Inc., was honored Friday by the Ohio Venture Association as a Venture of Year Award Finalist. Founded in 2004 to develop proprietary stem cell and tissue engineering based therapies, Arteriocyte focuses on developing commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral cord blood, and cartilage) for delivery to injured tissues in order to speed repair and improve function.
› Verified 4 days ago
Ms. Renee Z Spring, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 79 S Pleasant St, Amherst, MA 01002 Phone: 413-253-2916 Fax: 413-253-2186 | |
Dr. Arthur C Friedman, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 76 Amity Pl, Amherst, MA 01002 Phone: 413-549-0339 | |
Jamie Danielle Daniels, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 96 N Pleasant St, Amherst, MA 01002 Phone: 413-461-0671 | |
Mrs. Catherine S. Talan, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 26 S Prospect St, Amherst, MA 01002 Phone: 413-253-5733 | |
Vivian Michaela Deangelis, MA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 409 Main St Ste 123, Amherst, MA 01002 Phone: 413-253-8839 | |
Duarji Maliek Rivas, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 48 N Pleasant St Ste 207, Amherst, MA 01002 Phone: 413-461-4042 Fax: 413-726-6001 | |
Virginia L. Durnford, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19 Beech St, Amherst, MA 01002 Phone: 413-549-5757 |